CLAIM #48272 · Pfizer Inc (PFE) · 2023Q2 earnings call · Aug 1, 2023 · due Dec 31, 2023
“So, yes, we're looking forward to share the data later this year for you.”
Chris Boshoff · Chief Oncology R&D Officer
PENDING
graded after results covering Dec 31, 2023 are reported
Verify independently
SEC filings for PFE ↗ · Claim quote is verbatim from the 2023Q2 earnings call.